Fig. 4From: MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinomamiR-625-3p inhibits cisplatin-induced apoptosis. A miR-625-3p decreased caspase 3/7 activity in OVCAR3 cells treated with cisplatin in dose dependent manner. B miR-625-3p decreased caspase 3/7 activity in OVCAR4 cells treated with cisplatin in dose dependent manner. C-D miR-625-3p regulates BAX and BCL-2 expression in OVCAR3 and OVCAR4 cells treated with cisplatinBack to article page